MMJ Recs

JUNE 15, 2022

There are many treatments that can be utilized along with MMJ products to alleviate pain, such as medications, physical therapy, and massage. The best pain management physicians collaborate with the patient to develop a treatment regimen that works best for them as an individual. Pain Treatment Specialists.

Patients 52

Patients Treatment Clinical Trials Therapy 52

Veriheal

SEPTEMBER 18, 2020

Conventional forms of treatment are often accompanied by adverse side effects but there is hope for effective treatment with fewer side effects. . million of NWS Health funding for their Cannabinoid Therapeutics and Brain and Mind Centre to see if cannabidiol can be that effective treatment for spinal cord injury.

Treatment 98

Treatment Chronic Pain Research and Development CBD 98

Veriheal

MARCH 2, 2024

In December of 2023, the country recently made a new move towards reform that could stimulate the cannabidiol (CBD) industry and provide many patients, such as those with epilepsy , with access to potentially life-changing medical treatments. The post Is Weed Legal in Japan?

Legalization 105

Legalization Epilepsy Clinical Trials THC 105

MMJ Recs

MAY 9, 2024

In this instance, medical cannabis offers a promising alternative or complementary treatment option. For veterans considering medical marijuana as a treatment option, it’s essential to approach its usage with careful consideration and understanding.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

FloridaMarijuana.net

AUGUST 16, 2018

Dementia cannot be confirmed until a patient is deceased. Dementia is hard on the patient, and often harder on the family or caregivers. The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. It is caused by physical changes in the brain.

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

Cannabis Law Report

OCTOBER 4, 2021

One of the known beneficial uses of psilocybin is as a palliative care tool for patients with advanced illness who suffer from anxiety and/or depression. A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions.

Therapy 52

Therapy Patients Law Clinical Trials 52

FloridaMarijuana.net

JUNE 13, 2018

More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to cancer treatments. This epidemic affects not only patients, but their families and caregivers. Cannabis has given cancer patients relief , improved their mood and anxiety, and relieved insomnia.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

Cannabis Law Report

DECEMBER 27, 2019

A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. Virtual Clinical Trials transcend geographic, mobility and economic barriers.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

JULY 27, 2021

This study represents a refreshing collaboration of scientists, clinicians, patients and advocates. It is our hope that this study may embolden clinicians and patients to effectively partner in considering these treatments.”. Based on these findings, he and study co-author Ryan Vandrey, Ph.D., About Realm of Caring.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

SpeedWeed

SEPTEMBER 17, 2021

The funding will allow MAPS Public Benefit Corporation (MAPS PBC) to activate a team to evaluate the scope of the lack of resources needed for TBI treatment. . Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Cannabis Law Report

AUGUST 10, 2022

The lead investigators are Jacobo Mintzer , MD, MBA, Brigid Reynolds , ANP-BC, and the Alzheimer’s Clinical Trial Consortium (ACTC).The This trial benefits from passionate lead investigators, a world-renowned sponsor institution and funding from the US National Institute of Health. MediPharm Labs Corp.

Clinical Trials 52

Clinical Trials Medicine Pharmaceutical THC 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Key Responsibilities.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Cannabis Law Report

DECEMBER 9, 2021

Nue Life launched its proprietary nue.app on November 8 to increase access to psychedelic treatment as a catalyst for lasting change. MAPS is sponsoring the most advanced psychedelic therapy research in the world: Phase 3 clinical trials of MDMA-assisted therapy for PTSD. MIAMI , Dec. ” About Nue Life.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

FloridaMarijuana.net

AUGUST 15, 2018

Most commonly, patients report that tingling and numbness occur, usually in the hands and feet. Additionally, the ACPA reported on a clinical trial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. Neuropathy, or nerve damage, effects over 30 million Americans.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

SpeedWeed

MAY 22, 2021

The US Food and Drug Administration (FDA) has just approved a new clinical trial that will allow therapists to legally use MDMA. For this Phase 1 trial, MAPS will recruit 150 therapists that are currently being trained to conduct MDMA-assisted therapy sessions for PTSD. .

Clinical Trials 52

Clinical Trials Therapy Legalization Research and Development 52

Veriheal

AUGUST 31, 2020

At Veriheal, education and diversity are at the center of our core values. Choosing only 10 winners for the $10,000 in scholarships among the strong applications we received from multiple disciplines and concentrations in higher education—from students of all backgrounds and interests—was extremely difficult. Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

AUGUST 17, 2021

Improving Patient Outcomes with Real-time Feedback via Smart Inhalers and Portable and Lightweight Oxygen Concentrators for Increasing Home-Based Therapy is a Key Growth Opportunity. Therapeutic Medical Devices are Preferred by Physicians and Patients for Acute and Chronic Respiratory Conditions. The Strategic Imperative. Cognita Labs.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Cannabis Law Report

JANUARY 19, 2022

Congressman Moran introduced the AUTISM Educators Act in 2012, which funded partnerships between public schools and higher education and non-profit organizations to promote teaching skills for educators working with high functioning autism students. The Company also operates an infrastructure business based in India.

Clinical Trials 52

Clinical Trials Research and Development Education Therapy 52

MMJ Recs

DECEMBER 22, 2023

The AIDS epidemic in the 1980s brought attention to the potential benefits of marijuana in alleviating symptoms such as nausea and appetite loss associated with the disease and its treatment. Another influential factor is the growing emphasis on individual autonomy and patient choice in healthcare.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). About MAPS Public Benefit Corporation (MAPS PBC). Key Responsibilities.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. I never thought that would have been possible,” he said. However, the results were ultimately inconsistent. Opioids are a good medicine.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

DECEMBER 9, 2021

(the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (“cGMP”) of AP-188 (“ N , N -Dimethyltryptamine or DMT”) at Canadian manufacturer Dalton Pharma Services.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Veriheal

OCTOBER 13, 2020

Elevated levels of stress can even land these individuals in more discomfort, with IBD patients risking hospitalization due to inflammation. Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? What is IBS? What is the Difference Between IBD and IBS?

Digestion 123

Digestion Treatment Conditions Research and Development 123

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. – Phase 2 Trial Underway. Highlights from the presentation include: Declining PSA levels in treated patients. Declining circulating tumor cell (CTC) count in treated patients. Phase 2 trial underway. Abstract Number: 5015.

Data 100

Data Research and Development Clinical Trials Therapy 100

Cannabis Law Report

AUGUST 18, 2022

Smith , a partner with the firm and co-leader of the firm’s Life Sciences & Health Effects Team, will lead the practice, bringing together scientist-attorneys and experienced litigators to support clients that are driving innovation in mental health treatments. Tweet this. However, change appears imminent.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

AUGUST 21, 2019

Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said current treatments for adults suffering severe symptoms were “not cost effective”. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Key Responsibilities.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Veriheal

JUNE 7, 2021

It turns out that this blissful drug, MDMA, has the potential to be used effectively as a treatment for certain conditions- some of which are in urgent need of effective medical assistance. . MDMA has also reportedly been used with over 1,000 individuals in clinical trials , with no adverse effects to report. . What is MDMA?

Therapy 82

Therapy Treatment Conditions Clinical Trials 82

CannaTech

SEPTEMBER 16, 2018

Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. Shedding Stigma and Promoting Patient Access.

Education 66

Education Medicine Clinical Trials Patients 66

The Blunt Truth

DECEMBER 23, 2020

Many questions remain regarding the science, safety, effectiveness and quality of products containing CBD,” and further stated, “We remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD’s safety. Actions Speak Louder Than Words.

CBD 103

CBD Food Safety Clinical Trials 103

Cannabis Law Report

SEPTEMBER 20, 2021

KWC is a limited liability corporation formed under the laws of Arizona , which operates 10 ketamine infusion treatment clinics, across Arizona , Colorado , Florida , Illinois , Minnesota , Nevada , Texas , and Washington. Transaction Highlights.

Treatment 52

Treatment Media Research and Development Patients 52

Cannabis Law Report

OCTOBER 17, 2019

The introduction of these protocols will take the form of clinical trials and research that will include the usage of specific strains of cannabis that aid in chronic pain and cancer treatments. Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. A doctor who applies to the TGA on behalf of a patient must provide a clinical justification.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

NOVEMBER 16, 2019

Current barriers to patient access to medicinal cannabis in Australia. On 14 November 2019, the Senate referred an inquiry into the current barriers to patient access to medicinal cannabis in Australia to the Senate Community Affairs References Committee for inquiry and report by 12 February 2020.

Clinical Trials 58

Clinical Trials Access Medicine Patients 58

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. . How Do CBD Drug Interactions Occur? topiramate. zonisamide.

CBD 98

CBD THC Conditions Medicine 98

Veriheal

MARCH 23, 2023

Aside from Japan legalizing medical marijuana and forging a legal pathway that enables patients to use drugs made from cannabis plants, the amended legal law also seeks to criminalize the use of marijuana. . ‘1948 Law No. Moving forward, the government plans on implementing new laws as a way of preventing drug abuse among young people.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66